Sean P Pitroda Selected Research

Sean P Pitroda Research Topics

Disease

36	Neoplasms (Cancer) 03/2024 - 04/2009
20	Neoplasm Metastasis (Metastasis) 03/2024 - 04/2009
4	Aneuploidy (Aneuploid) 01/2024 - 12/2022
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2019
4	Breast Neoplasms (Breast Cancer) 08/2017 - 04/2009
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 11/2018
3	Lung Neoplasms (Lung Cancer) 01/2018 - 04/2009
2	Pneumonia (Pneumonitis) 11/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 11/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 02/2019 - 03/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Hypersensitivity (Allergy) 10/2022
1	Glossopharyngeal Nerve Diseases (Glossopharyngeal Neuralgia) 01/2022
1	Disease Progression 01/2022
1	Bites and Stings (Sting) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Residual Neoplasm 08/2017
1	Genomic Instability 08/2017
1	Inflammation (Inflammations) 01/2012
1	Carcinogenesis 05/2010
1	Adenocarcinoma of Lung 05/2010
1	Necrosis 05/2009

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2010
5	Immune Checkpoint InhibitorsIBA 01/2024 - 10/2021
5	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 05/2010
4	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2015
3	NivolumabIBA 01/2023 - 10/2021
3	InterferonsIBA 01/2021 - 05/2016
3	pembrolizumabIBA 12/2020 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 02/2019
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2024 - 02/2019
2	IpilimumabIBA 01/2023 - 01/2022
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 02/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	AntigensIBA 01/2019 - 05/2010
2	LuciferasesIBA 11/2016 - 06/2015
2	tdTomatoIBA 11/2016 - 06/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 05/2010
2	Mucin-1 (CA 15-3 Antigen)IBA 04/2009 - 04/2009
2	Oncogene Proteins (Oncogene Protein)IBA 04/2009 - 04/2009
1	Chemokine CXCL10IBA 03/2024
1	NexusIBA 12/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	N 30IBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Cetuximab (Erbitux)FDA Link 01/2023
1	urelumabIBA 10/2021
1	cabiralizumabIBA 10/2021
1	B7-H1 AntigenIBA 01/2021
1	AndrogensIBA 01/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	bicalutamide (Casodex)FDA LinkGeneric 01/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Capecitabine (Xeloda)FDA Link 02/2019
1	MethyltransferasesIBA 01/2019
1	Decitabine FDA Link 01/2019
1	olaparibIBA 11/2018
1	fedratinibIBA 01/2018
1	AnthracyclinesIBA 08/2017
1	Phenobarbital (Luminal)FDA Link 08/2017
1	Interferon Type IIBA 05/2016
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2014
1	CytokinesIBA 01/2012
1	Conditioned Culture MediaIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 05/2010
1	Interferon-betaIBA 05/2010
1	ChemokinesIBA 05/2010
1	Type I Tumor Necrosis Factor ReceptorsIBA 05/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2009
1	Interferon-gamma (Interferon, gamma)IBA 05/2009
1	LigandsIBA 05/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2009
1	Tamoxifen FDA LinkGeneric 04/2009
1	LipidsIBA 04/2009
1	Estrogen Receptor alphaIBA 04/2009
1	CholesterolIBA 04/2009
1	Transcription Factors (Transcription Factor)IBA 04/2009

Therapy/Procedure

20	Therapeutics 01/2024 - 06/2009
16	Radiotherapy 03/2024 - 01/2019
9	Immunotherapy 02/2023 - 01/2021
5	Drug Therapy (Chemotherapy) 01/2023 - 03/2014
2	Transurethral Resection of Bladder 01/2024 - 02/2019
2	Cystectomy 01/2024 - 02/2019
2	Chemoradiotherapy 01/2024 - 02/2019
2	Radioimmunotherapy 10/2021 - 01/2021
1	Particle Accelerators 01/2022
1	Drug Tapering 01/2022
1	Splenectomy 11/2016